The Guardian: Shareholders urged to push for cheaper pneumonia drugs
“Shareholders are being urged to use the annual general meetings of Pfizer and GlaxoSmithKline to put pressure on the companies to lower the price of their life-saving pneumonia vaccines…” (Kollewe, 4/27).

Thomson Reuters Foundation: Charity urges price cut for pneumonia vaccine for poor children
“Global charity Médecins Sans Frontières delivered a petition with hundreds of thousands of signatures to pharmaceutical giant Pfizer Inc. on Wednesday, asking the drugmaker to slash the price of its pneumonia vaccine for poor children. Supporters of a proposal to cut the vaccine price to $5 U.S. per needy child took their petition, and a baby’s crib covered with signatures, to the company’s New York City headquarters on the eve of its annual shareholder meeting. They made the same request of GlaxoSmithKline (GSK), which also makes a vaccine to prevent pneumonia…” (Malo, 4/27).